1Fitzpatrick TB. The validity and practicality of sun-reactive skin types Ⅰ through Ⅵ. Arch Dermatol 1988 ; 124(6) : 869 - 871.
2Lebwohl M, Christophers E, Langley R, et al. An international, randomized, double- blind, placebo- controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis. Arch Dermatol 2003; 159(6) :719 - 727.
3Ozawa M, Ferenczi K, Kikuchi T, et al. 312- nanometer ultraviolet B light (narrow - band UVB) induces apoptosis of T cells within psoriatic lesions. J Exp Med 1999; 189(4) :711 - 718.
4Bandow GD, Koo JY. Narrow - band ultraviolet B radiation: a review of the current literature. Int J Dermatol 2004;43:555- 561.
5Duthie MS, Kimber I, Norval M. The effects of ultraviolet radiation on the human immune system. Br J Dermatol 1999; 140(6) :995 - 1009.
6Hofer A, Fink - Puches R, Kerl H, et al. Comparison of phototherapy with near vs. far erythemogenic doses of narrow- band ultraviolet B in patients with psoriasis. Br J Dermatol 1998;138(1):96- 100.
7Gordon PM, Diffey BL, Mathews JN, et al. A randomized comparison of narrow- band TL- 01 phototherapy and PUVA photochemotherapy for psoriasis. J Am Acad Dermatol 1999;41(5 Pt 1) :728 - 732.
9Cameron H, Dawe RS, Yule S, et al. A randomized, observer- blinded trial of twice vs. three times weekly narrowband ultraviolet B phototherapy for chronic plaque psoriasis. Br J Dermatol 21302; 147(5) :973 - 978.
